エピソード

  • CAR T Cells and T-Cell Therapies for Cancer
    2024/11/04

    CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss "CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.”

    Related Content:

    • CAR T Cells and T-Cell Therapies for Cancer
    • Translational Science Reviews—A New JAMA Review
    続きを読む 一部表示
    18 分
  • Diagnosis and Treatment of Peptic Ulcer Disease
    2024/10/28

    Peptic ulcer disease affects approximately 1% of the population in the US, and H pylori is a common cause of peptic ulcer disease. Author Nimish Vakil, MD, a gastroenterologist from the University of Wisconsin, Madison, discusses current evidence regarding diagnosis and treatment of peptic ulcer disease with JAMA Deputy Editor Mary McGrae McDermott, MD.

    Related Content:

    • Peptic Ulcer Disease
    続きを読む 一部表示
    22 分
  • Strategies for Helping Patients Navigate High Prescription Drug Costs
    2024/10/21

    High prescription costs are a major barrier to the optimal treatment of many health conditions. Prescribers need tools to help patients find the lowest drug costs. Author Hussain S. Lalani, MD, MPH, MSc, of Brigham and Women's Hospital and Harvard Medical School joins JAMA Senior Editor Anne R. Cappola, MD, ScM, to discuss "Strategies to Help Patients Navigate High Prescription Drug Costs."

    Related Content:

    • Strategies to Help Patients Navigate High Prescription Drug Costs
    • Strategies to Help Patients Afford Their Medicines in the US
    続きを読む 一部表示
    13 分
  • Preexposure Prophylaxis (PrEP) Options for HIV
    2024/10/14

    Even though highly effective medications are currently available to prevent HIV, there are about 1.3 million new infections worldwide each year. Monica Gandhi, MD, MPH, of the University of California San Francisco joins JAMA Senior Editor Karen E. Lasser, MD, MPH, to discuss preexposure prophylaxis (PrEP) for HIV.

    Related Content:

    • Preexposure Prophylaxis (PrEP) for HIV
    • What Is Doxycycline Postexposure Prophylaxis?
    続きを読む 一部表示
    14 分
  • Update on Over-the-Counter (OTC) Contraception
    2024/10/09

    In July 2023, the US Food and Drug Administration (FDA) approved Opill, a daily progestin-only oral contraceptive for over-the-counter sale to people of all ages. Daniel Grossman, MD, discusses this and more with JAMA Associate Editor Melissa A. Simon, MD, MPH.

    Related Content:

    • Over-the-Counter Oral Contraceptives
    • Over-the-Counter Oral Contraceptive Pills
    • Over-the-Counter Progestin-Only Oral Contraceptives
    続きを読む 一部表示
    13 分
  • Dialysis for Chronic Kidney Failure
    2024/10/02

    Selection of hemodialysis or peritoneal dialysis and timing of dialysis initiation are influenced by patient symptoms, laboratory trajectories, patient preferences, and therapy cost and availability; shared decision-making is key. Jennifer E. Flythe, MD, MPH, from the University of North Carolina, discusses dialysis for chronic kidney failure with JAMA Deputy Editor Kristin L. Walter, MD, MS.

    Related Content:

    • Dialysis for Chronic Kidney Failure
    続きを読む 一部表示
    22 分
  • Diagnosis and Treatment of Chronic Spontaneous Urticaria
    2024/09/26

    Chronic spontaneous urticaria affects approximately 1% of the general population worldwide, impairs patients’ quality of life, and is associated with multiple comorbidities. Pavel Kolkhir, MD, discusses the current evidence on the epidemiology, pathophysiology, diagnosis, and treatment of chronic spontaneous urticaria with JAMA Senior Editor Karen E. Lasser, MD, MPH.

    Related Content:

    • Chronic Spontaneous Urticaria
    続きを読む 一部表示
    17 分
  • Diagnosis and Treatment of Community-Acquired Pneumonia (CAP)
    2024/09/16

    Community-acquired pneumonia is associated with approximately 740 000 hospitalizations and 41 000 deaths in the US annually. JAMA Review authors Scott A. Flanders, MD, and Valerie M. Vaughn, MD, MSc, discuss diagnosis and treatment of community-acquired pneumonia with JAMA Deputy Editor Mary McGrae McDermott, MD.

    Related Content:

    • Community-Acquired Pneumonia
    続きを読む 一部表示
    23 分